MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is Canvuparatide (...
Leadership
Steven L. Hoerter
Executive Chairperson
Peter Kent Hawryluk MBA
CEO, President & Director
Salomon Azoulay M.D.
Chief Medical Officer
John W. Smither CPA
Interim Chief Financial Officer
Pete De Spain
Senior Vice President of Investor Relations & Corporate Communications
Michelle Graham
Chief Human Resources Officer
Michael A. Dorato DABT, Ph.D.
Sr. Vice President of Discovery & Non-Clinical Development
Chatan Charan Ph.D.
Senior VP of Pharmaceutical Development & Chemistry, Manufacturing and Controls
